Evidence map›Paper›PMID 22521850›Full record

ArticleVaccine2012

Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigens.

Charles G Gauci, César M Jayashi, Armando E Gonzalez, Julia Lackenby, Marshall W Lightowlers

Open access · hybridAbstract read
In one paragraph

Article in Vaccine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. The Genomes of Two Strains ofFrontiers in cellular and infection microbiology · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Metazoan Parasite Vaccines: Present Status and Future Prospects.Frontiers in cellular and infection microbiology · 2018
    Review
  9. Article
  10. Article
  11. Neurocysticercosis: A disease of neglect.Tropical parasitology · 2013
    Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Charles G GauciUniversity of Melbourne, Faculty of Veterinary Science, Werribee, Victoria 3030, Australia. charlesg@unimelb.edu.au
César M Jayashi
Armando E Gonzalez
Julia Lackenby
Marshall W Lightowlers
University of Melbourne · AUNational University of San Marcos · PEVictoria University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recombinant antigens from the oncosphere stage of the parasite Taenia solium were expressed in Escherichia coli. The TSOL16, TSOL45-1A and TSOL45-1B recombinant antigens, each consisting of fibronectin type III (FnIII) domain S, were produced as fusion proteins with glutathione S-transferase (GST) and maltose binding protein (MBP). Groups of pigs were immunized twice with the GST fusions of the antigens and boosted a third time with the MBP fusions prior to receiving a challenge infection with T. solium eggs. The TSOL16 antigen was found to be capable of inducing high levels of immunity in pigs against a challenge infection with T. solium. Immunological investigations identified differences in immune responses in the pigs vaccinated with the various antigens. The results demonstrate that the TSOL16 antigen could be a valuable adjunct to current porcine vaccination approaches and may allow the further development of new vaccination strategies against T. solium cysticercosis.

Indexed as

AnimalsAntigens, HelminthCysticercosisEscherichia coliGene ExpressionImmunizationRecombinant Fusion ProteinsSwineSwine DiseasesTaenia soliumVaccines, SyntheticAntigens, HelminthRecombinant Fusion ProteinsVaccines, Synthetic

Identifiers

PMID22521850
PMCPMC3383989
OpenAlexW2137830208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.